OQS
AQST icon

Occudo Quantitative Strategies’s Aquestive Therapeutics AQST Stock Holding History

Occudo Quantitative Strategies’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-56,545
Closed -$365K – 740
2025
Q4 		$365K Buy
+56,545
New +$352K 0.02% 456
2024
Q1 		– Sell
-35,267
Closed -$71.2K – 728
2023
Q4 		$71.2K Sell
35,267
-24,562
-41% -$43.4K 0.01% 729
2023
Q3 		$91.5K Sell
59,829
-24,526
-29% -$42.2K 0.01% 882
2023
Q2 		$139K Buy
+84,355
New +$153K 0.01% 896

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Occudo Quantitative Strategies's AQST Position: Q1 2026 in Review

Occudo Quantitative Strategies sold out of Aquestive Therapeutics (AQST) in Q1 2026, closing a stake of 56,545 shares — an estimated $365K sold.

Occudo Quantitative Strategies first reported a position in AQST in Q2 2023 and held it in 4 quarters. The position peaked at $365K in Q4 2025. 179 funds tracked by Wall St. Rank hold AQST as of Q1 2026.

  • Occudo Quantitative Strategies reported no remaining Aquestive Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 56,545 Aquestive Therapeutics shares in Q1 2026, an estimated $365K.
  • Occudo Quantitative Strategies first reported a position in Aquestive Therapeutics in Q2 2023 and held it in 4 quarters.
  • Occudo Quantitative Strategies's Aquestive Therapeutics position peaked at $365K in Q4 2025.
  • 179 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q1 2026.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2026, filed 15 May 2026.